Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of low frequency artemisinin resistance mutations, C469Y, P553L and A675V, and fixed antifolate resistance mutations in asymptomatic primary school children in Kenya.
Osoti V, Wamae K, Ndwiga L, Gichuki PM, Okoyo C, Kepha S, Keitany K, Kandie R, Aricha S, Kiplagat R, Mwandawiro C, Bejon P, Snow RW, Ochola-Oyier LI. Osoti V, et al. Among authors: ochola oyier li. BMC Infect Dis. 2025 Jan 16;25(1):73. doi: 10.1186/s12879-025-10462-z. BMC Infect Dis. 2025. PMID: 39819451 Free PMC article.
Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.
Lugano D, Kutima B, Kimani M, Sigilai A, Gitonga J, Karani A, Akech D, Karia B, Ziraba AK, Maina A, Lambisia A, Omuoyo D, Mugo D, Lucinde R, Owuor S, Konyino G, Newman J, Bailey D, Nduati E, Githinji G, Agoti CN, Bejon P, Scott JAG, Agweyu A, Kagucia W, Warimwe GM, Sande C, Ochola-Oyier LI, Nyagwange J. Lugano D, et al. Among authors: ochola oyier li. BMC Infect Dis. 2024 Dec 28;24(1):1474. doi: 10.1186/s12879-024-10367-3. BMC Infect Dis. 2024. PMID: 39732637 Free PMC article.
Regional action needed to halt antimalarial drug resistance in Africa.
Martinez-Vega R, Ishengoma DS, Gosling R, Rosenthal PJ, Dondorp A, Barnes KI, Nsanzabana C, Djimde AA, Ochola-Oyier LI, Tibenderana J, Chimumbwa J, Golassa L, Kapologwe NA, Mbacham WF, Kamya MR, Fidock DA, Komatsu R, von Seidlein L, Dhorda M. Martinez-Vega R, et al. Among authors: ochola oyier li. Lancet. 2025 Jan 4;405(10472):7-10. doi: 10.1016/S0140-6736(24)02706-5. Epub 2024 Dec 12. Lancet. 2025. PMID: 39674185 No abstract available.
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang R, Osoti V, Wamae K, Ndwiga L, Muteru K, Ningwa A, Tuju J, Kinyanjui S, Osier F, Marsh K, Bejon P, Idro R, Ochola-Oyier LI. Ogwang R, et al. Among authors: ochola oyier li. Antimicrob Agents Chemother. 2024 Sep 4;68(9):e0157623. doi: 10.1128/aac.01576-23. Epub 2024 Aug 13. Antimicrob Agents Chemother. 2024. PMID: 39136465 Free PMC article.
Editorial: Malaria molecular epidemiology current situation in Africa.
Tandoh KZ, Duah-Quashie NO, Raman J, Ochola-Oyier LI. Tandoh KZ, et al. Among authors: ochola oyier li. Front Epidemiol. 2024 Apr 3;4:1400612. doi: 10.3389/fepid.2024.1400612. eCollection 2024. Front Epidemiol. 2024. PMID: 38633210 Free PMC article. No abstract available.
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.
Datoo MS, Dicko A, Tinto H, Ouédraogo JB, Hamaluba M, Olotu A, Beaumont E, Ramos Lopez F, Natama HM, Weston S, Chemba M, Compaore YD, Issiaka D, Salou D, Some AM, Omenda S, Lawrie A, Bejon P, Rao H, Chandramohan D, Roberts R, Bharati S, Stockdale L, Gairola S, Greenwood BM, Ewer KJ, Bradley J, Kulkarni PS, Shaligram U, Hill AVS; R21/Matrix-M Phase 3 Trial Group. Datoo MS, et al. Lancet. 2024 Feb 10;403(10426):533-544. doi: 10.1016/S0140-6736(23)02511-4. Epub 2024 Feb 1. Lancet. 2024. PMID: 38310910 Free article. Clinical Trial.
57 results